News

Boosting SA's vaccine production

06 Sep 2024
“Only 1% of vaccines used in Africa are made on the continent. Most are imported, leaving Africa as a consumer rather than a producer,” said Prof Glenda Gray, former president of the South African Medical Research Council. News24 (6 Sept 2024),
[READ MORE]

RAF cases are crippling the Gauteng High Court

06 Sep 2024
“Hundreds of Road Accident Fund (RAF) cases are clogging the court roll in Gauteng and lawyers say the organisation is not making enough effort to ensure cases are finalised quickly.” - Daily Maverick (4 Sept 2024).
[READ MORE]

Don’t cancel NHI because of corruption, says Health Minister

06 Sep 2024
It would be wrong to cancel NHI because of corruption, said Health Minister Aaron Motsoaledi at a recent Business and Civil Society Summit. - News24 (6 September 2024).
[READ MORE]

BUSA criticises government’s handling of NHI Act

06 Sep 2024
Business Unit SA (BUSA) CEO Cas Coovadia lashed out at the government for not engaging in discussions about the NHI and for the hostile rhetoric against those questioning the Act, reported Business Day (6 September 2024).
[READ MORE]

OPINION How NHI can bridge South Africa’s healthcare gaps

05 Sep 2024
“Instead of driving a wedge between the public and private health sectors, it’s time to address the issues both sectors face,” wrote Foster Mohale in The Citizen (4 September 2024).
[READ MORE]

Ascendis returns to profit

05 Sep 2024
“Ascendis Health, a SA healthcare company valued at around R440m on the JSE, reported a small profit for the year ending in June 2024, showing signs of recovery after previous losses.” – News24 (4 Sept 2024).
[READ MORE]

Impact of AI in South Africa

05 Sep 2024
Artificial Intelligence (AI) is rapidly transforming healthcare in SA, moving from hype to practical applications, reported Spotlight (4 September 2024)
[READ MORE]

AfroCentric reports mixed results

04 Sep 2024
Business Day (3 September 2024) reported that AfroCentric announced a 0.4% increase in revenue compared with the previous year.
[READ MORE]

Aspen Pharmacare secures loan to boost medicine and vaccine development

04 Sep 2024
Aspen Pharmacare’s efforts to develop and manufacture medicines and vaccines for the African continent received a boost with the securing of a R9.9bn loan from World Bank’s International Finance Corporation (IFC), reported Business Day (3 September 2024).
[READ MORE]

Gauteng reports high HIV prevalence among 50-54-year-olds

04 Sep 2024
According to the latest report released by the Human Sciences Research Council’s (HSRC), Gauteng recorded a HIV prevalence peak of 32.2% among residents aged 50 to 54, reported, Times Live 4 Sept 2024)
[READ MORE]

HASA suggests reviving abandoned healthcare reforms

03 Sep 2024
“SA’s healthcare landscape could undergo a transformative shift if previously abandoned reforms are reintroduced,” wrote Tamar Kahn in Business Day (3 September 2024).
[READ MORE]

Health Compact: BHF states its case

03 Sep 2024
“The second Presidential Health Compact, recently signed by the government alongside limited health sector stakeholders, claims to be a framework for cooperation to achieve positive healthcare outcomes. However, concerns are mounting that it serves primarily to push the legally contested and potentially unconstitutional National Health Insurance (NHI) Act,” wrote Katlego Mothudi,MD of the Board of Healthcare Funders in Business Day (3 September 2024).
[READ MORE]

CMS urged to clarify cover for autoimmune diseases

02 Sep 2024
The Autoimmune Association of SA (AASA) urged the Council for Medical Schemes (CMS), to provide clear guidelines regarding the extent to which medical schemes are required to cover expensive specialised treatments that are not commonly available in the public healthcare system. – Business Day (2 September 2024)
[READ MORE]

Discovery Life claims back to pre-Covid levels

19 Apr 2024
“Discovery Life distributed R10.3bn to its clients, a decrease from the R11bn paid the previous year,” reported Business Day (19April 2024)
[READ MORE]

Hundreds of websites found selling fake weight-loss drugs

16 Apr 2024
Reuters reported on 15 April that the cybersecurity company BrandShield has shut down over 250 websites selling counterfeit versions of popular drugs used for weight loss and diabetes treatment within the GLP-1 class.
[READ MORE]

Page 1 of 2 Next > >>

1	Disclaimer
	HEALTHMAN, do not guarantee the availability of services offered on this website ("the Services") or the accuracy of the information and/or images on this website. We make no representations or warranties, whether express or implied, and assume no liability or responsibility for the proper performance of this website and/or the Services and/or the information and/or images contained on this website, and the Services are thus used at your own risk. In particular we make no warrantee that the Services will meet your requirements, be uninterrupted, timely, and secure or error free.

2	Indemnification
	You, the user, accordingly indemnify and hold us harmless against all and any loss, liability, actions, suites, proceedings, costs, demands and damages of all and every kind, (including direct, indirect, special or consequential damages), and whether in an action based on contract, negligence or any other action, arising out of or in connection with the failure or delay in the performance of the Services offered on this website, or the use of the information and/or images available on this website.

3	Use of Services
	3.1	You may only use the Services for lawful purposes and you warrant that you shall not:
		3.1.1	1 other than for your personal and non-commercial use, store on your computer, or print copies of extracts from this website, and you may not, other than for your personal and non-commercial use, "mirror" or cache information provided via this website on your own server, or copy, adapt, modify or re-use the text or graphics from this website without prior written permission from HEALTHMAN.

4	Privacy
	4.1	Whilst your name and particulars which are supplied to us when registering for some of the Services will not automatically be made available to anyone, we nevertheless reserve the right to make information available to the authorities if required by law.
	4.2	We will not sell or rent any personally identifiable information about you to any third party. However monitoring or recording of your registration details may take place for business purposes to the extent permitted by law, such as for example quality control and training for the purposes of improving our Services. However, in these situations, we will not disclose information that could be used to personally identify you.
	4.3	We will adhere to our privacy policy the salient terms of which are available for you to link to and read from the home page of this website.
	4.4	You must notify us immediately should any of your information change.

5	Intellectual Property Rights
	You acknowledge that we own the intellectual property rights in and to this website, and that the unauthorized use thereof is expressly prohibited. The word or mark "HEALTHMAN", and "e2", however represented, including stylized representation, all associated logos and symbols and combinations of any of the a foregoing with another word or mark, used on this site, are the trademarks of HEALTHMAN.

6	Password
	You shall keep your password secure and warrant that no other person shall use the Services utilizing your password, and you acknowledge further that you are responsible for ensuring that no unauthorized access to the Services is obtained using your password, and that you will be liable for all such activities conducted pursuant to such use, whether authorized or not.

7	Termination and Variation
	We reserve the right to terminate the Services to you in particular, or to the public in general, without notice or reason, or to revise these terms and conditions at any time. Such changes will be posted on this website and be deemed to have been accepted by you if you continue using the Services. The obligation therefore is on you to review these terms and conditions at regular intervals.

8.	General
	8.1	These terms and conditions will be governed by and construed in accordance with the laws of South Africa.
	8.2	These terms and conditions are severable, in that if any provision is determined to be illegal or unenforceable by any court of competent jurisdiction, then such provision shall be deemed to have been deleted without affecting the remaining provisions of the terms and conditions.
	8.3	Our failure to exercise any particular rights or provision of these terms and conditions shall not constitute a waiver of such right or provision, unless acknowledged and agreed to by us in writing.
	8.4	These terms and conditions, as varied by us from time to time pursuant to clause 7, above constitute the sole agreement between yourself and ourselves.

1.	Content of Customer Information
	HEALTHMAN shall ensure that:
	1.1	customer information shall be obtained only for the purpose of delivering and improving the Services and will not be processed in any manner incompatible with this purpose;
	1.2	customer information shall be adequate, relevant and not excessive in relation to the abovementioned purpose for which it is collated and/or processed;
	1.3	customer information shall be accurate, and where necessary, kept up to date and reasonable steps shall be taken to ensure that information which is inaccurate and/or incomplete, having regard to the purpose for which it was collected, is erased or rectified;
	1.4	customer information shall be kept in a format which permits identification for no longer than is necessary for the purpose for which the information was collected or processed.

2	Customer Consent
	Customer information may only be processed if:
	2.1	the customer has unambiguously given his consent; or
	2.2	processing is necessary for:
		2.2.1	the performance of a contract to which the customer is a party; or
		2.2.2	in order to take steps at the request of the customer prior to entering into a contract; or
		2.2.3	for compliance with a legal obligation to which HEALTHMAN is subject; or
		2.2.4	the performance of a task carried out in the public interest or in the exercise of official authority vested in the recipient; or
		2.2.5	for purposes of the legitimate interest pursued by HEALTHMAN, except where such interest is overridden by the interest for fundamental rights as reflected in the constitution.

3.	Access to Customer Information
	HEALTHMAN shall ensure that:
	3.1	access to, or disclosure of customer information will not be authorized without the documented commitment of the intended recipient so as to maintain confidentiality and the rightful use of such information;
	3.2	access to customer information by HEALTHMAN personnel, contract workers, consultants, service providers or suppliers will be restricted to the level of access needed to effectively perform delegated or contracted duties and/or the level of service needed to render a reliable and effective service to HEALTHMAN customers.

4.	Preventative Measures
	HEALTHMAN shall ensure that appropriate technical and organizational measures shall be taken against the unauthorized access, processing or disclosure of customer information